Study on predictors for treatment efficacy of rituximab in patients with PLA2R-negative primary membranous nephropathy

Objective To evaluate the clinical efficacy of rituximab (RTX) in patients with phospholipase A2 receptor (PLA2R)-negative primary membranous nephropathy (PMN) presenting as nephrotic syndrome, and to identify predictors for treatment efficacy. Methods This retrospective cohort study included 19 bio...

Full description

Saved in:
Bibliographic Details
Main Author: XU Lili, HU Xiaofan, LI Hao, WANG Weiming
Format: Article
Language:zho
Published: Editorial Office of Journal of Diagnostics Concepts & Practice 2025-06-01
Series:Zhenduanxue lilun yu shijian
Subjects:
Online Access:https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1756094078939-2131883305.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!